Multicenter DSC-MRI-Based Radiomics Predict IDH Mutation in Gliomas

Georgios C Manikis1, Georgios S Ioannidis1, Loizos Siakallis2

  • 1Computational BioMedicine Laboratory (CBML), Foundation for Research and Technology-Hellas (FORTH), 70013 Heraklion, Greece.

Cancers
|August 27, 2021
PubMed
Summary

This study introduces dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) radiomics to predict isocitrate dehydrogenase (IDH) mutations in gliomas. Image standardization significantly improved prediction accuracy, revealing texture complexity correlations with IDH mutation status.

Related Concept Videos